Reflecting on CPHI & PMEC China 2026: A Successful Wrap-Up in Shanghai

As CPHI & PMEC China 2026 officially concludes day, Raytor Instruments Co., Ltd extends its heartfelt gratitude to all the global pharmaceutical professionals, formulation scientists, regulatory leaders, and partners who visited us at Booth W16A18.

Over the past three days, the industry-wide dialogue surrounding analytical automation, data integrity compliance, and novel drug delivery system (NDDS) testing has been deeply inspiring. We are proud to have showcased our core ecosystem designed to resolve critical laboratory bottlenecks:

🔹 RT614-ST (14-Vessel Dissolution): Accelerating comparative parallel studies.
🔹 RT710 (Flow-Through Cell): Enhancing precision in complex formulation release kinetics.
🔹 RT814 (Transdermal Diffusion): Streamlining high-throughput automated IVRT/IVPT workflows.
🔹 RT510 (Automated Media Prep): Ensuring standard-compliant, foam-free deaeration.

While the exhibition has come to an end, our commitment to driving lab efficiency and supporting global regulatory approvals remains steadfast. The collaborative projects initiated this week mark the beginning of exciting milestones ahead.

If you did not have the opportunity to connect with our application scientists on-site, we invite you to continue the conversation. Please contact our technical sales division at Sales@raytor.com or visit www.raytor.com for technical documentation or tailored inquiries.

Wishing all of our industry colleagues a safe and pleasant journey home.